Noninvasive Hemodynamic Insight for Heart Failure Care
Coredio estimates catheter grade intracardiac hemodynamics using wearables, AI, and digital twins
The Challenge
Insufficient Monitoring
Current standard of care is either non-existent or inaccurate for effective heart failure management
Limited Access Between Visits
Care team dont have access to echocardiograms or catheterizations to get accurate hemodynamic status.
Invasive &
Costly
Accurate insight at-home or out-patient is only available through costly and invasive implantables.
The Challenge
Insufficient Monitoring
Current standard of care is either non-existent or inaccurate for effective heart failure management
Limited Access Between Visits
Care team dont have access to echocardiograms or catheterizations to get accurate hemodynamic status.
Invasive & Costly
Accurate insight at-home or out-patient is only available through costly and invasive implantables.
Join the clinicians who are exploring the future of cardiovascular monitoring
with Coredio team
FDA
Disclaimer: Coredio CPSE™ has received FDA Breakthrough Device Designation. The device is not yet cleared by the FDA for commercial use. Indications for Use are subject to FDA review under the 510(k) process.
Disclaimer: Coredio CPSE™ has received FDA Breakthrough Device Designation. The device is not yet cleared by the FDA for commercial use. Indications for Use are subject to FDA review under the 510(k) process.